NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $21.78 -1.47 (-6.32%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$21.36▼$24.2350-Day Range$15.83▼$24.7952-Week Range$5.65▼$25.74Volume11.50 million shsAverage Volume7.49 million shsMarket Capitalization$4.68 billionP/E RatioN/ADividend YieldN/APrice Target$19.07 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Hims & Hers Health alerts: Email Address Hims & Hers Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.56 Rating ScoreUpside/Downside12.4% Downside$19.07 Price TargetShort InterestBearish13.13% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.52Based on 23 Articles This WeekInsider TradingSelling Shares$18.64 M Sold Last QuarterProj. Earnings Growth90.00%From $0.20 to $0.38 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.55 out of 5 starsMedical Sector511th out of 936 stocksOffices & Clinics Of Medical Doctors Industry5th out of 8 stocks 2.3 Analyst's Opinion Consensus RatingHims & Hers Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 9 buy ratings, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageHims & Hers Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted13.13% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently increased by 12.81%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HIMS. Previous Next 2.5 News and Social Media Coverage News SentimentHims & Hers Health has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 23 news articles for Hims & Hers Health this week, compared to 9 articles on an average week.Search Interest180 people have searched for HIMS on MarketBeat in the last 30 days. This is an increase of 114% compared to the previous 30 days.MarketBeat FollowsOnly 31 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -35% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold 854.82% more of their company's stock than they have bought. Specifically, they have bought $1,951,763.00 in company stock and sold $18,635,842.00 in company stock.Percentage Held by Insiders17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Hims & Hers Health are expected to grow by 90.00% in the coming year, from $0.20 to $0.38 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is -2,178.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is -2,178.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 13.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Hims & Hers Health Stock (NYSE:HIMS)Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.Read More HIMS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HIMS Stock News HeadlinesJuly 26 at 6:35 AM | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $47,377.15 in StockJuly 24 at 7:08 AM | marketbeat.comCan the New CEO Revive This Struggling Telehealth Stock? (HIMS)Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 19, 2024 | marketbeat.comIs This Telehealth Stock a Buy After the Recent Pullback?Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.July 17, 2024 | insidertrades.comIrene Becklund Sells 472 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockJuly 17, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Michael Chi Sells 9,313 SharesJuly 11, 2024 | insidertrades.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 2,335 Shares of StockJuly 9, 2024 | insidertrades.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) CEO Sells 188,888 Shares of StockJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 26 at 6:02 AM | forbes.comRed-Hot Prescription Stock Flashing A Bullish SignalJuly 25 at 9:00 AM | investorplace.com3 Game-Changing Stocks on the Edge of Unprecedented GainsJuly 25 at 4:44 AM | nz.finance.yahoo.comHIMS Jul 2024 26.000 callJuly 25 at 4:44 AM | msn.comHims & Hers Health, Inc. (HIMS) Stock Moves -1.14%: What You Should KnowJuly 24 at 6:33 AM | investorplace.com3 Once-in-a-Lifetime Stock Opportunities You Can't Miss: July 2024July 24 at 12:31 AM | benzinga.comWhat's Going On With Hims & Hers Shares Today?July 22, 2024 | msn.comUnsafe Ozempic knockoffs flooding the marketJuly 22, 2024 | benzinga.comWhy Hims & Hers Heath Shares Are Surging TodayJuly 22, 2024 | msn.comHims & Hers has a 'long future' in selling off-brand Ozempic, former Novo Nordisk executive saysSee More Headlines Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2024Today7/26/2024Next Earnings (Confirmed)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryHealthcare Current SymbolNYSE:HIMS CUSIPN/A CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees1,046Year FoundedN/APrice Target and Rating Average Stock Price Target$19.07 High Stock Price Target$26.00 Low Stock Price Target$10.00 Potential Upside/Downside-13.3%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E Ratio110.00 P/E GrowthN/ANet Income$-23,550,000.00 Net Margins-0.24% Pretax Margin0.05% Return on Equity-0.70% Return on Assets-0.55% Debt Debt-to-Equity RatioN/A Current Ratio2.80 Quick Ratio2.48 Sales & Book Value Annual Sales$959.40 million Price / Sales4.93 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book13.66Miscellaneous Outstanding Shares214,786,000Free Float176,747,000Market Cap$4.73 billion OptionableOptionable Beta1.08 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Andrew Dudum (Age 35)Co-Founder, Chairman & CEO Comp: $1.98MMr. Yemi Okupe (Age 38)Chief Financial Officer Comp: $1.01MMs. Melissa Baird (Age 46)Chief Operating Officer Comp: $1.05MMs. Soleil Teubner Boughton (Age 45)Chief Legal Officer & Corporate Secretary Comp: $928.7kDr. Patrick Carroll M.D. (Age 66)Chief Medical Officer, Member of Medical Advisory Board & Director Comp: $54kMr. Mike Chi (Age 44)Chief Commercial Officer Comp: $998kMs. Irene A. Becklund (Age 39)Senior VP, Controller & Principal Accounting Officer Comp: $361.12kMs. Khobi BrooklynChief Communications OfficerMs. Amee ParekhSenior Vice President of Human ResourcesDr. Peter Stahl M.D.Senior VP & Member of Medical Advisory BoardMore ExecutivesKey CompetitorsNateraNASDAQ:NTRAFresenius Medical CareNYSE:FMSOption Care HealthNASDAQ:OPCHPACS GroupNYSE:PACSGuardant HealthNASDAQ:GHView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 273,473 shares on 7/26/2024Ownership: 0.316%State of Michigan Retirement SystemBought 320,000 shares on 7/26/2024Ownership: 0.233%Allspring Global Investments Holdings LLCBought 39,943 shares on 7/26/2024Ownership: 0.024%Soleil BoughtonSold 2,335 sharesTotal: $47,377.15 ($20.29/share)Legacy Capital Group California Inc.Bought 84,167 shares on 7/22/2024Ownership: 0.039%View All Insider TransactionsView All Institutional Transactions HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $8.90 at the start of the year. Since then, HIMS stock has increased by 144.7% and is now trading at $21.78. View the best growth stocks for 2024 here. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) released its quarterly earnings results on Monday, May, 6th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.03. Hims & Hers Health's revenue for the quarter was up 45.8% on a year-over-year basis. Who are Hims & Hers Health's major shareholders? Top institutional investors of Hims & Hers Health include Bank of New York Mellon Corp (0.32%), State of Michigan Retirement System (0.23%), QRG Capital Management Inc. (0.07%) and Oak Ridge Investments LLC (0.06%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Michael Chi, Oluyemi Okupe, Patrick Harrison Carroll, Soleil Boughton, Jules A Maltz, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Lynne Chou O'keefe and Jack Abraham. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:HIMS) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
